By fine-tuning the inferred CTS topic distributions guided by the breast cancer subtypes, we deconvolve the average differential gene expression into CTS expression changes, thereby enabling discovery of the subtype-specific aberrance of the gene regulatory programs. The gene discussed is TTR; the disease is breast carcinoma.